AbCellera Biologics Inc.

ABCL · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$156,325$133,320$386,535$476,142
Short-Term Investments$469,289$627,265$499,950$246,835
Receivables$92,130$64,382$38,593$160,576
Inventory$0$1,107$1,532$1,672
Other Curr. Assets$33,626$45,911$98,881$44,575
Total Curr. Assets$751,370$871,985$1,025,491$929,800
Property Plant & Equip (Net)$340,429$287,696$217,255$111,616
Goodwill$47,806$47,806$47,806$47,806
Intangibles$42,113$120,425$131,502$148,392
Long-Term Investments$82,297$65,938$72,522$50,313
Tax Assets$0$0$5,300$7,408
Other NC Assets$96,538$94,244$41,031$23,234
Total NC Assets$609,183$616,109$515,416$388,769
Other Assets$0$0$0$0
Total Assets$1,360,553$1,488,094$1,540,907$1,318,569
Liabilities
Payables$34,350$25,509$14,828$14,924
Short-Term Debt$4,621$6,158$5,583$3,652
Tax Payable$0$0$0$35,683
Deferred Revenue$21,179$18,958$21,612$7,536
Other Curr. Liab.$16,462$68,388$76,297$58,881
Total Curr. Liab.$76,612$119,013$118,320$120,676
LT Debt$60,743$71,222$76,675$36,413
Deferred Rev, NC$155,593$104,110$60,317$60,758
Deferred Tax Liab, NC$10,052$30,612$33,178$37,370
Other NC Liab.$1,469$10,819$19,140$37,619
Total NC Liab.$227,857$216,763$189,310$172,160
Other Liabilities$0$0$0$0
Cap. Leases$65,364$77,380$82,258$40,065
Total Liabilities$304,469$335,776$307,630$292,836
Equity
Pref Stock$0$0$0$0
Common Stock$777,171$753,199$734,365$722,430
Retained Earnings$116,930$279,787$426,185$267,666
AOCI-$4,378-$1,720-$1,391$280
Other Equity$166,361$121,052$74,118$35,357
Total Equity$1,056,084$1,152,318$1,233,277$1,025,733
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,360,553$1,488,094$1,540,907$1,318,569
Net Debt-$90,961-$55,940-$304,277-$436,077
AbCellera Biologics Inc. (ABCL) Financial Statements & Key Stats | AlphaPilot